Controlled efficacy trial confirming toltrazuril resistance in a field isolate of ovine Eimeria spp.

Autor: Odden A; Faculty of Veterinary Medicine, Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Kyrkjevegen 332/334, 4325, Sandnes, Norway. ane.odden@nmbu.no., Enemark HL; Department of Animal Health and Food Safety, Norwegian Veterinary Institute, P.O. Box 750 Sentrum, 0106, Oslo, Norway., Ruiz A; Parasitology Unit, Department of Animal Pathology, Faculty of Veterinary Medicine, University of Las Palmas de Gran Canaria, 35416 Arucas, Las Palmas, Spain., Robertson LJ; Faculty of Veterinary Medicine, Department of Food Safety and Infection Biology, Norwegian University of Life Sciences, P.O. Box 369 Sentrum, 0102, Oslo, Norway., Ersdal C; Faculty of Veterinary Medicine, Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Kyrkjevegen 332/334, 4325, Sandnes, Norway., Nes SK; Faculty of Veterinary Medicine, Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Kyrkjevegen 332/334, 4325, Sandnes, Norway., Tømmerberg V; Animalia, Norwegian Meat and Poultry Research Centre, P.O. Box 396, Økern, 0513, Oslo, Norway., Stuen S; Faculty of Veterinary Medicine, Department of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Kyrkjevegen 332/334, 4325, Sandnes, Norway.
Jazyk: angličtina
Zdroj: Parasites & vectors [Parasit Vectors] 2018 Jul 05; Vol. 11 (1), pp. 394. Date of Electronic Publication: 2018 Jul 05.
DOI: 10.1186/s13071-018-2976-4
Abstrakt: Background: Coccidiosis due to Eimeria spp. infections in lambs causes increased mortality and substantial production losses, and anticoccidials are important for control of the infection. Anticoccidial resistance has been reported in poultry and swine, and we recently described reduced toltrazuril efficacy in ovine Eimeria spp. in some Norwegian sheep farms using a newly developed faecal oocyst count reduction test (FOCRT). The aim of the present study was to use a controlled efficacy trial to assess the efficacy of toltrazuril against a field isolate suspected of being resistant.
Methods: Twenty lambs, 17-22 days old and raised protected against exposure to coccidia, were infected with a field isolate of 100,000 Eimeria spp. oocysts. This isolate was obtained from a farm with a previously calculated drug efficacy of 56% (95% confidence interval: -433.9 to 96.6%). At day 7 post-infection, 10 of the lambs were orally treated with 20 mg/kg toltrazuril (Baycox Sheep vet., Bayer Animal Health), while the other 10 lambs (controls) were given physiological saline. Clinical examinations were conducted, and weight gains recorded. Daily faecal samples were scored for diarrhoea on a scale from 1 to 5, and oocyst excretion was determined using a modified McMaster technique. Oocysts were morphologically identified to species level. At 17-24 days post-infection, the lambs were euthanized and necropsied.
Results: The tested Eimeria isolate was resistant against toltrazuril, and resistance was seen in both pathogenic and non-pathogenic species. In addition, no significant differences in faecal score, growth, gross pathology or histological changes were identified between the two groups. The pathogenic E. ovinoidalis was the dominant species, and no significant difference in the individual prevalence of E. ovinoidalis post-treatment was found between treated (66.9%) and control lambs (61.9%). Other species identified included E. crandallis/weybridgensis, E. parva, E. marsica, E. faurei, E. pallida, E. ahsata and E. bakuensis.
Conclusions: This study confirms toltrazuril resistance in ovine Eimeria spp.; in addition, the data support the use of FOCRT as an appropriate tool for field evaluation of anticoccidial efficacy. Due to limited anticoccidial treatment alternatives, these findings may have important implications for the sheep industry, particularly in northern Europe.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje